miR-139-5p is a regulator of metastatic pathways in breast cancer

RNA

Volumn 19, Issue 12, 2013, Pages 1767-1780

  Krishnan, Keerthana ^a   Steptoe, Anita L ^a   Martin, Hilary C ^a,h   Pattabiraman, Diwakar R ^b   Nones, Katia ^a   Waddell, Nic ^a   Mariasegaram, Mythily ^c   Simpson, Peter T ^c   Lakhani, Sunil R ^a,c,d   Vlassov, Alexander ^e   Grimmond, Sean M ^a,g   Cloonan, Nicole ^a,f  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^e Life Technologies   (United States)

^f QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^g UNIVERSITY OF GLASGOW   (United Kingdom)

^h UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Biomarker; Breast cancer; miRNA

Indexed keywords

BIOTIN; MESSENGER RNA; MICRORNA; MICRORNA 139 5P; MITOGEN ACTIVATED PROTEIN KINASE; RHO FACTOR; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; WNT PROTEIN;

ARTICLE; BIOINFORMATICS; BREAST CANCER; CANCER CELL; CANCER GROWTH; CELL INVASION; CELL MIGRATION; HUMAN; HUMAN CELL; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

BIOMARKER; BREAST CANCER; MIRNA;

BASE SEQUENCE; BINDING SITES; CARCINOMA, DUCTAL, BREAST; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DNA REPLICATION; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICRORNAS; NEOPLASM INVASIVENESS; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TRIPLE NEGATIVE BREAST NEOPLASMS;

EID: 84888408364     PISSN: 13558382     EISSN: 14699001     Source Type: Journal    
DOI: 10.1261/rna.042143.113     Document Type: Article

References (86)

1. Adriaenssens E, Vanhecke E, Saule P, Mougel A, Page A, Romon R, Nurcombe V, Le Bourhis X, Hondermarck H. 2008. Nerve growth factor is a potential therapeutic target in breast cancer. Cancer Res 68: 346-351.
2. Asangani IA, Rasheed SA, Nikolova DA, Leupold JH, Colburn NH, Post S, Allgayer H. 2008. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 27: 2128-2136.
3. Aust S, Obrist P, Klimpfinger M, Tucek G, Jager W, Thalhammer T. 2005. Altered expression of the hormone- and xenobiotic-metabolizing sulfotransferase enzymes 1A2 and 1C1 in malignant breast tissue. Int J Oncol 26: 1079-1085.
4. Bao W, Fu HJ, Xie QS, Wang L, Zhang R, Guo ZY, Zhao J, Meng YL, Ren XL, Wang T, et al. 2011. HER2 interacts with CD44 to up-regulate CXCR4 via epigenetic silencing of microRNA-139 in gastric cancer cells. Gastroenterology 141: 2076-2087 e2076.
5. Barber MA, Welch HC. 2006. PI3K and RAC signalling in leukocyte and cancer cell migration. Bull Cancer 93: E44-E52.
6. Benjamini Y, Hochberg Y. 1995. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc Series B (Methodological) 57: 289-300.
7. Bentwich I. 2005. Prediction and validation of microRNAs and their targets. FEBS Lett 579: 5904-5910.
8. Bhowmick NA, Neilson EG, Moses HL. 2004. Stromal fibroblasts in cancer initiation and progression. Nature 432: 332-337.
9. Blanco MA, Kang Y. 2011. Signaling pathways in breast cancer metastasis - novel insights from functional genomics. Breast Cancer Res 13: 206.
10. Buchholz TA, Garg AK, Chakravarti N, Aggarwal BB, Esteva FJ, Kuerer HM, Singletary SE, Hortobagyi GN, Pusztai L, Cristofanilli M, et al. 2005. The nuclear transcription factor κB/bcl-2 pathway correlates with pathologic complete response to doxorubicin-based neoadjuvant chemotherapy in human breast cancer. Clin Cancer Res 11: 8398-8402.
11. Buck MB, Knabbe C. 2006. TGF-β signaling in breast cancer. Ann N Y Acad Sci 1089: 119-126.
12. Bundy LM, Sealy L. 2003. CCAAT/enhancer binding protein beta (C/EBPβ)-2 transforms normalmammary epithelial cells and induces epithelial tomesenchymal transition in culture. Oncogene 22: 869-883.
13. Cardoso F, Castiglione M. 2009. Locally recurrent or metastatic breast cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 20: 15-18.
14. Chaudhary A, King WG, Mattaliano MD, Frost JA, Diaz B, Morrison DK, Cobb MH, Marshall MS, Brugge JS. 2000. Phosphatidylinositol 3-kinase regulates Raf1 through Pak phosphorylation of serine 338. Curr Biol 10: 551-554.
15. Cheang MC, Voduc D, Bajdik C, Leung S, McKinney S, Chia SK, Perou CM, Nielsen TO. 2008. Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype. Clin Cancer Res 14: 1368-1376.
16. Clevers H, Nusse R. 2012. Wnt/β-catenin signaling and disease. Cell 149: 1192-1205.
17. Cloonan N, Brown MK, Steptoe AL, Wani S, Chan WL, Forrest AR, Kolle G, Gabrielli B, Grimmond SM. 2008. The miR-17-5p microRNA is a key regulator of the G1/S phase cell cycle transition. Genome Biol 9: R127.
18. Cloonan N, Wani S, Xu Q, Gu J, Lea K, Heater S, Barbacioru C, Steptoe AL, Martin HC, Nourbakhsh E, et al. 2011. MicroRNAs and their isomiRs function cooperatively to target common biological pathways. Genome Biol 12: R126.
19. Cronan MR, Nakamura K, Johnson NL, Granger DA, Cuevas BD, Wang JG, Mackman N, Scott JE, Dohlman HG, Johnson GL. 2011. Defining MAP3 kinases required for MDA-MB-231 cell tumor growth and metastasis. Oncogene 31: 3889-3900.
20. Du P, Kibbe WA, Lin SM. 2008. lumi: A pipeline for processing Illumina microarray. Bioinformatics 24: 1547-1548.
21. Du J, Sun C, Hu Z, Yang Y, Zhu Y, Zheng D, Gu L, Lu X. 2010. Lysophosphatidic acid induces MDA-MB-231 breast cancer cells migration through activation of PI3K/PAK1/ERK signaling. PLoS One 5: e15940.
22. Fabian MR, Sonenberg N, Filipowicz W. 2010. Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem 79: 351-379.
23. Fan Q, He M, Deng X, Wu WK, Zhao L, Tang J, Wen G, Sun X, Liu Y. 2012. Derepression of c-Fos caused by microRNA-139 down-regulation contributes to the metastasis of human hepatocellular carcinoma. Cell Biochem Funct 31: 319-324.
24. Farazi TA, Horlings HM, Ten Hoeve JJ, Mihailovic A, Halfwerk H, Morozov P, Brown M, Hafner M, Reyal F, van Kouwenhove M, et al. 2011. MicroRNA sequence and expression analysis in breast tumors by deep sequencing. Cancer Res 71: 4443-4453.
25. Fidler IJ. 2003. The pathogenesis of cancer metastasis: The 'seed and soil' hypothesis revisited. Nat Rev Cancer 3: 453-458.
26. Gennarino VA, D'Angelo G, Dharmalingam G, Fernandez S, Russolillo G, Sanges R, Mutarelli M, Belcastro V, Ballabio A, Verde P, et al. 2012. Identification of microRNA-regulated gene networks by expression analysis of target genes. Genome Res 22: 1163-1172.
27. Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshid G, Vadas MA, Khew-Goodall Y, Goodall GJ. 2008. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 10: 593-601.
28. Guo H, Hu X, Ge S, Qian G, Zhang J. 2012. Regulation of RAP1B by miR-139 suppresses human colorectal carcinoma cell proliferation. Int J Biochem Cell Biol 44: 1465-1472.
29. Hasseine LK, Hinault C, Lebrun P, Gautier N, Paul-Bellon R, Van Obberghen E. 2009. miR-139 impacts FoxO1 action by decreasing FoxO1 protein in mouse hepatocytes. Biochem Biophys Res Commun 390: 1278-1282.
30. Hirata H, Ueno K, Shahryari V, Tanaka Y, Tabatabai ZL, Hinoda Y, Dahiya R. 2012. Oncogenic miRNA-182-5p targets Smad4 and RECK in human bladder cancer. PLoS One 7: e51056.
31. Hong J, Zhou J, Fu J, He T, Qin J, Wang L, Liao L, Xu J. 2011. Phosphorylation of serine 68 of Twist1 by MAPKs stabilizes Twist1 protein and promotes breast cancer cell invasiveness. Cancer Res 71: 3980-3990.
32. Huang C, Jacobson K, Schaller MD. 2004. MAP kinases and cell migration. J Cell Sci 117: 4619-4628.
33. Huntzinger E, Izaurralde E. 2011. Gene silencing by microRNAs: Contributions of translational repression and mRNA decay. Nat Rev Genet 12: 99-110.
34. Khalil S, Tan GA, Giri DD, Zhou XK, Howe LR. 2012. Activation status of Wnt/ss-catenin signaling in normal and neoplastic breast tissues: Relationship to HER2/neu expression in human and mouse. PLoS One 7: e33421.
35. Kim J, Shao Y, Kim SY, Kim S, Song HK, Jeon JH, Suh HW, Chung JW, Yoon SR, Kim YS, et al. 2008. Hypoxia-induced IL-18 increases hypoxia-inducible factor-1α expression through a Rac1-dependent NF-κB pathway. Mol Biol Cell 19: 433-444.
36. Kim B, Nam HJ, Pyo KE, Jang MJ, Kim IS, Kim D, Boo K, Lee SH, Yoon JB, Baek SH, et al. 2011. Breast cancer metastasis suppressor 1 (BRMS1) is destabilized by the Cul3-SPOP E3 ubiquitin ligase complex. Biochem Biophys Res Commun 415: 720-726.
37. Korpal M, Lee ES, Hu G, Kang Y. 2008. The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J Biol Chem 283: 14910-14914.
38. Korpal M, Ell BJ, Buffa FM, Ibrahim T, Blanco MA, Celia-Terrassa T, Mercatali L, Khan Z, Goodarzi H, Hua Y, et al. 2011. Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization. Nat Med 17: 1101-1108.
39. Krishnan K, Steptoe AL, Martin HC, Wani S, Nones K, Waddell N, Mariasegaram M, Simpson PT, Lakhani SR, Gabrielli B, et al. 2013. MicroRNA-182-5p targets a network of genes involved in DNA repair. RNA 19: 230-242.
40. Lau KS, Dennis JW. 2008. N-Glycans in cancer progression. Glycobiology 18: 750-760.
41. Lee CH, Kuo WH, Lin CC, Oyang YJ, Huang HC, Juan HF. 2013. MicroRNA-regulated protein-protein interaction networks and their functions in breast cancer. Int J Mol Sci 14: 11560-11606.
42. Li RY, Chen LC, Zhang HY, Du WZ, Feng Y, Wang HB, Wen JQ, Liu X, Li XF, Sun Y, et al. 2013. MiR-139 inhibits Mcl-1 expression and potentiates TMZ-induced apoptosis in glioma. CNS Neurosci Ther 19: 477-483.
43. Lin SM, Du P, Huber W, Kibbe WA. 2008. Model-based variance-stabilizing transformation for Illumina microarray data. Nucleic Acids Res 36: e11.
44. Liu Z, Liu J, Segura MF, Shao C, Lee P, Gong Y, Hernando E, Wei JJ. 2012. MiR-182 overexpression in tumourigenesis of high-grade serous ovarian carcinoma. J Pathol 228: 204-215.
45. Ma L, Teruya-Feldstein J, Weinberg RA. 2007. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 449: 682-688.
46. Ma Y, Zhang P, Wang F, Zhang H, Yang Y, Shi C, Xia Y, Peng J, Liu W, Yang Z, et al. 2012. Elevated oncofoetal miR-17-5p expression regulates colorectal cancer progression by repressing its target gene P130. Nat Commun 3: 1291.
47. Maeda K, Chung YS, Onoda N, Ogawa M, Kato Y, Nitta A, Arimoto Y, Kondo Y, Arakawa T, Sowa M. 1996. Association of tumor cell proliferation with lymph node metastasis in early gastric cancer. Oncology 53: 1-5.
48. Makrodouli E, Oikonomou E, Koc M, Andera L, Sasazuki T, Shirasawa S, Pintzas A. 2011. BRAF and RAS oncogenes regulate Rho GTPase pathways to mediate migration and invasion properties in human colon cancer cells: A comparative study. Mol Cancer 10: 118.
49. Marchio C, Weigelt B, Reis-Filho JS. 2010. Adenoid cystic carcinomas of the breast and salivary glands (or 'The strange case of Dr Jekyll and Mr Hyde' of exocrine gland carcinomas). J Clin Pathol 63: 220-228.
50. Maroni P, Bendinelli P, Matteucci E, Desiderio MA. 2007. HGF induces CXCR4 and CXCL12-mediated tumor invasion through Ets1 and NF-κB. Carcinogenesis 28: 267-279.
51. Mascaux C, Laes JF, Anthoine G, Haller A, Ninane V, Burny A, Sculier JP. 2009. Evolution of microRNA expression during human bronchial squamous carcinogenesis. Eur Respir J 33: 352-359.
52. Matsuda T, Yamamoto T, Muraguchi A, Saatcioglu F. 2001. Cross-talk between transforming growth factor-β and estrogen receptor signaling through Smad3. J Biol Chem 276: 42908-42914.
53. Metzger-Filho O, Tutt A, de Azambuja E, Saini KS, Viale G, Loi S, Bradbury I, Bliss JM, Azim HA Jr, Ellis P, et al. 2012. Dissecting the heterogeneity of triple-negative breast cancer. J Clin Oncol 30: 1879-1887.
54. Moutsatsou P, Papavassiliou AG. 2008. The glucocorticoid receptor signalling in breast cancer. J Cell Mol Med 12: 145-163.
55. Naushad SM, Reddy CA, Rupasree Y, Pavani A, Digumarti RR, Gottumukkala SR, Kuppusamy P, Kutala VK. 2011. Cross-talk between one-carbon metabolism and xenobiotic metabolism: Implications on oxidative DNA damage and susceptibility to breast cancer. Cell Biochem Biophys 61: 715-723.
56. Padua D, Zhang XH, Wang Q, Nadal C, Gerald WL, Gomis RR, Massague J. 2008. TGFβ primes breast tumors for lung metastasis seeding through angiopoietin-like 4. Cell 133: 66-77.
57. Panizo-Santos A, Sola I, Vega F, de Alava E, Lozano MD, Idoate MA, Pardo-Mindan J. 2000. Predicting metastatic risk of gastrointestinal stromal tumors: Role of cell proliferation and cell cycle regulatory proteins. Int J Surg Pathol 8: 133-144.
58. Park HS, Park S, Kim JH, Lee JH, Choi SY, Park BW, Lee KS. 2010. Clinicopathologic features and outcomes of metaplastic breast carcinoma: Comparison with invasive ductal carcinoma of the breast. Yonsei Med J 51: 864-869.
59. Previdi S, Maroni P, Matteucci E, Broggini M, Bendinelli P, Desiderio MA. 2010. Interaction between human-breast cancer metastasis and bone microenvironment through activated hepatocyte growth factor/Met and β-catenin/Wnt pathways. Eur J Cancer 46: 1679-1691.
60. Ramsay AK, McCracken SR, Soofi M, Fleming J, Yu AX, Ahmad I, Morland R, Machesky L, Nixon C, Edwards DR, et al. 2011. ERK5 signalling in prostate cancer promotes an invasive phenotype. Br J Cancer 104: 664-672.
61. Ridolfi RL, Rosen PP, Port A, Kinne D, Mike V. 1977. Medullary carcinoma of the breast: A clinicopathologic study with 10 year follow-up. Cancer 40: 1365-1385.
62. Romashkova JA, Makarov SS. 1999. NF-κB is a target of AKT in antiapoptotic PDGF signalling. Nature 401: 86-90.
63. Romero-Cordoba S, Rodriguez-Cuevas S, Rebollar-Vega R, Quintanar-Jurado V, Maffuz-Aziz A, Jimenez-Sanchez G, Bautista-Pina V, Arellano-Llamas R, Hidalgo-Miranda A. 2012. Identification and pathway analysis of microRNAs with no previous involvement in breast cancer. PLoS One 7: e31904.
64. Scheel C, Eaton EN, Li SH, Chaffer CL, Reinhardt F, Kah KJ, Bell G, GuoW, Rubin J, Richardson AL, et al. 2011. Paracrine and autocrine signals induce and maintain mesenchymal and stem cell states in the breast. Cell 145: 926-940.
65. Schepeler T, Holm A, Halvey P, Nordentoft I, Lamy P, Riising EM, Christensen LL, Thorsen K, Liebler DC, Helin K, et al. 2012. Attenuation of the β-catenin/TCF4 complex in colorectal cancer cells induces several growth-suppressive microRNAs that target cancer promoting genes. Oncogene 31: 2750-2760.
66. Schlange T, Matsuda Y, Lienhard S, Huber A, Hynes NE. 2007. Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation. Breast Cancer Res 9: R63.
67. Schlessinger K, Hall A, Tolwinski N. 2009. Wnt signaling pathways meet Rho GTPases. Genes Dev 23: 265-277.
68. Shan SW, Fang L, Shatseva T, Rutnam ZJ, Yang X, Du W, Lu WY, Xuan JW, Deng Z, Yang BB. 2013. Mature miR-17-5p and passenger miR-17-3p induce hepatocellular carcinoma by targeting PTEN, GalNT7 and vimentin in different signal pathways. J Cell Sci 126: 1517-1530.
69. Sheldahl LC, Park M, Malbon CC, Moon RT. 1999. Protein kinase C is differentially stimulated by Wnt and Frizzled homologs in a G-protein-dependent manner. Curr Biol 9: 695-698.
70. Shen K, Liang Q, Xu K, Cui D, Jiang L, Yin P, Lu Y, Li Q, Liu J. 2012. MiR-139 inhibits invasion and metastasis of colorectal cancer by targeting the type I insulin-like growth factor receptor. Biochem Pharmacol 84: 320-330.
71. Shirdel EA, Xie W, Mak TW, Jurisica I. 2011. NAViGaTing the micronome - using multiple microRNA prediction databases to identify signalling pathway-associated microRNAs. PLoS One 6: e17429.
72. Smirnova T, Zhou ZN, Flinn RJ, Wyckoff J, Boimel PJ, Pozzuto M, Coniglio SJ, Backer JM, Bresnick AR, Condeelis JS, et al. 2012. Phosphoinositide 3-kinase signaling is critical for ErbB3-driven breast cancer cell motility and metastasis. Oncogene 31: 706-715.
73. Smyth GK. 2004. Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3: doi: 10.2202/1544-6115.1027.
74. Sood P, Krek A, Zavolan M, Macino G, Rajewsky N. 2006. Cell-type-specific signatures of microRNAs on target mRNA expression. Proc Natl Acad Sci 103: 2746-2751.
75. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, et al. 2005. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci 102: 15545-15550.
76. Sun Y, Fang R, Li C, Li L, Li F, Ye X, Chen H. 2010. Hsa-mir-182 suppresses lung tumorigenesis through down regulation of RGS17 expression in vitro. Biochem Biophys Res Commun 396: 501-507.
77. Tolias KF, Cantley LC, Carpenter CL. 1995. Rho family GTPases bind to phosphoinositide kinases. J Biol Chem 270: 17656-17659.
78. Valastyan S, Reinhardt F, Benaich N, Calogrias D, Szasz AM, Wang ZC, Brock JE, Richardson AL, Weinberg RA. 2009. A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell 137: 1032-1046.
79. Vega FM, Ridley AJ. 2008. Rho GTPases in cancer cell biology. FEBS Lett 582: 2093-2101.
80. Wei Q, Li YX, Liu M, Li X, Tang H. 2012. MiR-17-5p targets TP53INP1 and regulates cell proliferation and apoptosis of cervical cancer cells. IUBMB Life 64: 697-704.
81. Wong CC, Wong CM, Tung EK, Au SL, Lee JM, Poon RT, Man K, Ng IO. 2011. The microRNA miR-139 suppresses metastasis and progression of hepatocellular carcinoma by down-regulating Rho-kinase 2. Gastroenterology 140: 322-331.
82. Workman C, Jensen LJ, Jarmer H, Berka R, Gautier L, Nielser HB, Saxild HH, Nielsen C, Brunak S, Knudsen S. 2002. A new nonlinear normalization method for reducing variability in DNA microarray experiments. Genome Biol 3: doi: 10.1186/gb-2002-3-9-research0048.
83. Xue G, Restuccia DF, Lan Q, Hynx D, Dirnhofer S, Hess D, Ruegg C, Hemmings BA. 2012. Akt/PKB-mediated phosphorylation of Twist1 promotes tumor metastasis via mediating cross-talk between PI3K/Akt and TGF-β signaling axes. Cancer Discov 2: 248-259.
84. Yerushalmi R, Hayes MM, Gelmon KA. 2009. Breast carcinoma - rare types: Review of the literature. Ann Oncol 20: 1763-1770.
85. Zavadil J, Bottinger EP. 2005. TGF-β and epithelial-to-mesenchymal transitions. Oncogene 24: 5764-5774.
86. Zhu S, Wu H, Wu F, Nie D, Sheng S, Mo YY. 2008. MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res 18: 350-359.